awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33409608-0BE92D9C-5D84-4517-BAD5-0DEDB61F5D5D
Q33409608-0BE92D9C-5D84-4517-BAD5-0DEDB61F5D5D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33409608-0BE92D9C-5D84-4517-BAD5-0DEDB61F5D5D
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas.
P2860
Q33409608-0BE92D9C-5D84-4517-BAD5-0DEDB61F5D5D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33409608-0BE92D9C-5D84-4517-BAD5-0DEDB61F5D5D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ad4124cfeffb6391c71cb17a7a510074e6d43fc0
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).